<DOC>
	<DOCNO>NCT00512265</DOCNO>
	<brief_summary>The purpose study evaluate effect high-dose n-acetylcysteine inflammatory reaction , pulmonary morbidity , oxygenation quality life patient undergoing transthoracic , partial total resection esophagus cancer .</brief_summary>
	<brief_title>Influence N-Acetylcysteine Morbidity , Oxygenation Cytokine Levels Partial Total Esophagectomy Cancer</brief_title>
	<detailed_description>Cancer esophagus poor long term prognosis well high perioperative morbidity . Pulmonary complication play thereby major role . The standard procedure either combine transabdominal/transthoracic approach , allow good visualisation tumor radical surgery ( may increase R0 resection consequently overall survival ) blunt transhiatal technique . In Zurich , Basel Lucerne , combine technique standard procedure . The combined surgical approach , pre-existing pulmonary disorder , poor nutritional status release pro-inflammatory cytokine may important contribute factor pulmonary complication pneumonia , atelectasis , pleural effusion Acute Respiratory Distress Syndrome ( ARDS ) . N-Acetylcysteine ( NAC ) show direct indirect oxygen scavenge ability . In severe sepsis acute respiratory distress syndrome , positive effect NAC morbidity mortality discover . Aim study ass influence NAC morbidity , oxygenation parameter cytokine level . According power analysis , 90 patient include trial . A multicenter approach choose finish study within 3 year . Respective average number operation per institution year , follow distribution plan : Triemli Hospital 40 , University Hospital Basel 30 , Kantonsspital Lucerne 20 . Inclusion criterion trial patient undergoing thoraco-abdomino-cervical abdomino-thoracic esophagectomy cancer 20 90 year give informed consent . Exclusion criterion know allergy hypersensitivity NAC pregnancy . Patients randomise receive either high dose N-Acetylcysteine administer perioperatively postoperatively three day ( 150mg/kg perioperatively 50mg/kg day 1-3 ) placebo ( glucose 5 % ) . Pre- , peri- postoperatively cytokine ( IL-1 , IL-1ra , IL-6 , IL-8 , IL-10 , TNF-Î± ) , quantify enzyme-linked immuno assay ( ELISA ) blood , broncho-alveolar lavage lavage pleural space . Leucocytes , C-reactive protein , Procalcitonin oxygenation parameter ( arterial blood gas analyse = ABGA ) regularly measure . Morbidity mortality assess . Furthermore , patient ask complete quality life questionnaire ( EORTC QLQ-OES18 30 , SF-36 ) operation ( 12 , 24 , 36 month post-op ) .</detailed_description>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>elective , abdominothoracic esophagectomy elective , thoracoabdominocervical esophagectomy age 2090 year informed consent give emergency procedures patient increase bronchorrhoea hypersensitivity nacetylcysteine pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>n-acetylcysteine</keyword>
	<keyword>esophagectomy</keyword>
	<keyword>inflammatory reaction</keyword>
	<keyword>pulmonary morbidity</keyword>
</DOC>